- Complex generics development
- Oral solid dosage forms (IR, SR, MR, DR, Palletisation, HME)
- Liquid orals, Semi-solids, Onco products, Injectables
- Reverse engineering, Q1/Q2/Q3 estimation
- Formulation development using QbD & DOE
- Competitive Generic Therapy (CGT)